Cardiovascular disease: risk assessment and reduction, including lipid modification

used in the NHS annual health check for people with severe mental health conditions.) Recommendations for research The guideline committee has made the following key recommendations for research. 1 Simplifying risk assessment What is the effectiveness of age alone and other routinely available risk factors compared with the formal structured multifactorial risk assessment to identify people at high risk of developing CVD? [2014] 2 Statin treatment for older people What is the effectiveness of statin treatment in older people? [May 2023, amended December 2023] For a short explanation of why the committee made this recommendation for research, see the rationale section on lipid-lowering treatment for primary prevention of CVD. Full details of the evidence and the committee's discussion are in evidence review C: statins: efficacy and adverse effects. 3 Lipid-lowering treatment for people with type 1 diabetes What is the effectiveness of statins and/or other lipid-lowering treatment in people with type 1 diabetes? [May 2023, amended December 2023] For a short explanation of why the committee made this recommendation for research, see the rationale section on lipid-lowering treatment for primary prevention of CVD. Full details of the evidence and the committee's discussion are in evidence review C: statins: efficacy and
